Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging.
Ontology highlight
ABSTRACT: The tropomyosin receptor kinases family (TrkA, TrkB, and TrkC) supports neuronal growth, survival, and differentiation during development, adult life, and aging. TrkA/B/C downregulation is a prominent hallmark of various neurological disorders including Alzheimer's disease (AD). Abnormally expressed or overexpressed full-length or oncogenic fusion TrkA/B/C proteins were shown to drive tumorigenesis in a variety of neurogenic and non-neurogenic human cancers and are currently the focus of intensive clinical research. Neurologic and oncologic studies of the spatiotemporal alterations in TrkA/B/C expression and density and the determination of target engagement of emerging antineoplastic clinical inhibitors in normal and diseased tissue are crucially needed but have remained largely unexplore
SUBMITTER: Schirrmacher R
PROVIDER: S-EPMC6469173 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA